Botox Maker Settles Federal Marketing Charges



Botox manufacturer Allergan has agreed to plead guilty and pay $600 million to settle federal criminal and civil charges for marketing botox for uses not approved by the FDA, such as pain and headache.


Name:
E-mail:
Website:  
Please enter your comment below:
Please enter the text below:

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2014 a division of BLR All rights reserved.